SCHEMBL6589450

SCHEMBL6589450

Cc1cccc(C(=O)Nc2ccc(Cl)cc2)c1NC(=O)c1sc2ccccc2c1Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
F10 P00742 18/20 1.00
TP53 P04637 1/20 0.66
MAPT P10636 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
RXFP1 Q9HBX9 1/20 0.66
PRSS12 P56730 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6591788 0.94 F10 (0.88) F10TP53MAPTSMN1; SMN2RXFP1
SCHEMBL6590377 0.89 F10 (1.00) F10PRSS12
SCHEMBL6592989 0.88 F10 (1.00) F10TP53MAPTSMN1; SMN2RXFP1
SCHEMBL6592752 0.88 F10 (1.00) F10PRSS12
SCHEMBL5539701 0.88 F10 (0.82) F10PRSS12
SCHEMBL5539857 0.88 F10 (0.81) F10TP53MAPTSMN1; SMN2RXFP1
SCHEMBL6589997 0.88 F10 (1.00) F10TP53MAPTSMN1; SMN2RXFP1
SCHEMBL6228748 0.85 F10 (0.73) F10TP53MAPTSMN1; SMN2RXFP1
SCHEMBL6590270 0.83 F10 (1.00) F10PRSS12
SCHEMBL6592616 0.82 F10 (1.00) F10TP53MAPTSMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP claimed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US claimed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed